Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection

clinical trial

Details

Instance of: clinical trial
Start time: November 2007
End time: July 2009
Country: United States
Main subject: infectious mononucleosis
clinical trial phase: phase I clinical trial, phase II clinical trial
minimum age: 15
number of participants: 23
research site: University of Minnesota
short name: Mono6
study type: interventional study
title: Randomized, Placebo-Controlled, Double-Blind Study to Assess Clinical and Antiviral Activity of Valomaciclovir (EPB 348) in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection (Mono 6)

Nothing in the MetaHistoryBook collection references this item yet.